PDF (1731K)
摘要
目的 探讨住院患者接受不同异体血液成分输注与静脉血栓栓塞(venous thromboembolism,VTE)发生风险的关联,明确不同血液成分的血栓风险差异,并建立针对性的 VTE 风险预测模型。方法 采用回顾性队列研究,纳入 2024 年 11 月-2025 年 10 月在本院接受异体输血的住院患者 5 406 例,按 1 ∶1 最近邻匹配的倾向性评分未输血患者 5 402 例作为对照;匹配变量包括性别、年龄、VTE 风险评分、VTE 预防措施、合并肿瘤、抗菌药物使用、有创呼吸机使用,匹配容差为 0. 01,无放回抽样。 采用标准化均差(SMD)评估匹配质量,SMD<0. 1 视为基线均衡。 输血组按输注成分类型分层,采用卡方检验、Bonferroni 校正及多因素 Logistic 回归分析危险因素,将未平衡的 VTE 预防措施和抗菌药物使用强制纳入回归模型进行校正。 构建预测模型并以 ROC 曲线下面积、Hosmer-Lemeshow 检验进行验证,依据最大 Youden 指数确定最优截断值。结果 匹配后所有变量 SMD<0. 1,基线均衡可比。 输血组 VTE 发生率显著高于对照组(8. 7% vs 4. 3%,RR= 2. 02,95%CI:1. 74~ 2. 35,P<0. 001);不同输血亚组 VTE 发生率差异显著,血栓风险梯度为联合输注>血浆>红细胞≈血小板,其中联合输注组 VTE 发生率为 11. 7%,显著高于红细胞组(RR= 3. 20,95% CI:2. 41~4. 24,P<0. 001)、血浆组(RR = 1. 71,95% CI:1. 24 ~ 2. 35,P<0. 001) 与血小板组(RR = 6. 81,95% CI:2. 56 ~ 18. 06,P<0. 001)。 本研究构建的预测模型区分度与校准度良好,曲线下面积为 0. 800,依据 Youden 指数确定最优截断值为 0. 12,对应灵敏度 62. 3%,阴性预测值为 91. 4%。结论 异体输血是住院患者 VTE 的独立危险因素,不同血液成分血栓风险存在明显梯度;本研究构建的预测模型可实现输血患者 VTE 风险分层,为精准输血与患者血液管理提供依据。
Abstract
Objective To explore the association between transfusion of different allogeneic blood components and the risk of venous thromboembolism(VTE) in hospitalized patients, to clarify the differences in thrombotic risk among various blood components, and to develop a targeted VTE risk prediction model. Methods A retrospective cohort study was conducted, enrolling 5 406 hospitalized patients who received allogeneic blood transfusion in our hospital from November 2024 to October 2025. Using 1 ∶1 nearest neighbor propensity score matching(PSM), 5 402 non-transfused patients were selected as controls. The matching variables included sex, age, VTE risk score, VTE prophylaxis, comorbid tumor, use of antibiotics, and invasive mechanical ventilation, with a caliper of 0. 01 and sampling without replacement. Standardized mean difference(SMD) was used to assess matching quality, with SMD <0. 1 indicating balanced baseline characteristics. The transfusion group was stratified by the type of blood component transfused. The chi-square test with Bonferroni correction and multivariate logistic regression(including forced adjustment for the unbalanced variables VTE prophylaxis and antibiotic use) were used to analyze risk factors. A prediction model was constructed and validated using the area under the receiver operating characteristic(ROC) curve and the Hosmer-Lemeshow test. The optimal cut-off value was determined by the maximum Youden index. Results All variables showed SMD < 0. 1 after matching, indicating good baseline balance. The incidence of VTE was significantly higher in the transfusion group than in the control group(8. 7% vs 4. 3%, RR= 2. 02, 95% CI: 1. 74-2. 35, P< 0. 001). Significant differences in VTE incidence were observed among different transfusion subgroups, with a thrombotic risk gradient of combined transfusion > plasma > red blood cells ≈ platelets. The incidence of VTE in the combined transfusion subgroup was 11. 7%, which was significantly higher than that in the red blood cell subgroup(RR= 3. 20, 95% CI: 2. 41-4. 24, P<0. 001), plasma subgroup(RR = 1. 71, 95% CI: 1. 24-2. 35, P<0. 001), and platelet subgroup(RR= 6. 81, 95% CI: 2. 56-18. 06, P< 0. 001). The prediction model showed good discrimination and calibration, with an area under the ROC curve of 0. 800. The optimal cut-off value determined by the Youden index was 0. 12, corresponding to a sensitivity of 62. 3% and a negative predictive value of 91. 4%. Conclusion Allogeneic blood transfusion was an independent risk factor for VTE in hospitalized patients, with significant differences in thrombotic risk among different blood components. The prediction model developed in this study can achieve VTE risk stratification in transfused patients, providing evidence for precise transfusion therapy and patient blood management.
关键词
Key words
[Author(id=1329502147025449305, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=812579461@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502147088363867, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147025449305, language=EN, stringName=Tao CAO, firstName=Tao, middleName=null, lastName=CAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502147134501212, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147025449305, language=CN, stringName=曹涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000, bio={"content":"曹涛(1988-),男,主管技师,Email:812579461@qq.com
"}, bioImg=null, bioContent=曹涛(1988-),男,主管技师,Email:812579461@qq.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146949951829, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, xref=null, ext=[AuthorCompanyExt(id=1329502146962534742, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China), AuthorCompanyExt(id=1329502146979311959, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000)])]), Author(id=1329502147184832862, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502147247747424, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147184832862, language=EN, stringName=Yuan ZHOU, firstName=Yuan, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502147293884769, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147184832862, language=CN, stringName=周媛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146949951829, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, xref=null, ext=[AuthorCompanyExt(id=1329502146962534742, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China), AuthorCompanyExt(id=1329502146979311959, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000)])]), Author(id=1329502147344216419, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502147407130981, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147344216419, language=EN, stringName=Xianting KE, firstName=Xianting, middleName=null, lastName=KE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502147457462630, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147344216419, language=CN, stringName=柯贤婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146949951829, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, xref=null, ext=[AuthorCompanyExt(id=1329502146962534742, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China), AuthorCompanyExt(id=1329502146979311959, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000)])]), Author(id=1329502147507794280, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502147579097450, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147507794280, language=EN, stringName=Jinbo FAN, firstName=Jinbo, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502147621040491, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, authorId=1329502147507794280, language=CN, stringName=范金波, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502146949951829, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, xref=null, ext=[AuthorCompanyExt(id=1329502146962534742, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Transfusion Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000, China), AuthorCompanyExt(id=1329502146979311959, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407910959452731, companyId=1329502146949951829, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=十堰市太和医院(湖北医药学院附属医院) 输血医学科,湖北 十堰 442000)])])]
曹涛,周媛,柯贤婷,范金波.
输血成分对患者血栓风险的影响及预测模型构建[J].
中国输血杂志, 2026, 39(7): 867-873 DOI:10.13303/j.cjbt.issn.1004-549x.2026.07.008
| [1] |
JAFF M R. Venous thromboembolic disease[J].Ochsner J, 2002, 4(1):6-8.
|
| [2] |
COHEN A T, AGNELLI G, ANDERSON F A, et al. Venous thromboembolism(VTE) in Europe: the number of VTE events and associated morbidity and mortality[J].Thromb Haemost, 2007, 98(4):756-764.
|
| [3] |
RASKOB G E, ANGCHAISUKSIRI P, BLANCO A N, et al. Thrombosis: a major contributor to global disease burden[J].Arterioscler Thromb Vasc Biol, 2014, 34(11):2363-2371.
|
| [4] |
WENDELBOE A M, RASKOB G E. Global burden of thrombosis: epidemiologic aspects[J].Circ Res, 2016, 118(9):1340-1347.
|
| [5] |
院内静脉血栓栓塞症防治指南制定专家组 。 院内静脉血栓栓塞症防治指南(2022 版)[J].中华医学杂志,2022, 102(42):3338-3348.
|
| [6] |
Guideline Development Expert Group for the Prevention and Treatment of Nosocomial Venous Thromboembolism.Guidelines for the prevention and treatment of nosocomial venous thromboembolism(2022 edition)[J].Natl Med J China, 2022, 102(42):3338-3348.
|
| [7] |
HENKE P K, KAHN S R, PANNUCCI C J, et al. Call to action to prevent venous thromboembolism in hospitalized patients: a policy statement from the American Heart Association[J].Circulation, 2020, 141 (24): e914-e931.
|
| [8] |
World Health Organization. Global status report on blood safety and availability 2021[R]. Geneva: WHO,2022.
|
| [9] |
中华人民共和国国家卫生健康委员会 。 输血反应分类(WS/ T 624-2018)[S].北京:中国标准出版社, 2018.
|
| [10] |
National Health Commission of the People′s Republic of China. Classification of transfusion reactions(WS/ T 624-2018)[S]. Beijing: China Standards Press,2018.
|
| [11] |
LU H, WU F L, LI J J, et al. Irradiated red blood cell transfusion is associated with an increased incidence of deep vein thrombosis in trauma patients: a cohort study[J].BMC Anesthesiol, 2025, 25(1):400.
|
| [12] |
GOEL R, PATEL U E, CUSHING M M, et al. Association of perioperative red blood cell transfusions with venous thromboembolism in a North American registry[J].JAMA Surg, 2018, 153(9):826-833.
|
| [13] |
KIM B S, RAMAKANTH Y, KAUSHIK R, et al. Red blood cell transfusions and risk of postoperative venous thromboembolism[J].J Am Acad Orthop Surg, 2022, 30(13):e883-e891.
|
| [14] |
LEE B H, YEONJU Y, LEE R S, et al. The risk of venous thrombosis for erythropoiesis stimulating agents and blood transfusions in cancer patients: a nationwide population-based study in Korea[J].Blood, 2023, 142 (Suppl 1):1270.
|
| [15] |
PANDOR A, TONKINS M, GOODACRE S, et al. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review[J].BMJ Open, 2021, 11(7):e045672.
|
| [16] |
YIN Z J, HUANG Y J, CHEN Q L. Risk factor analysis and a new prediction model of venous thromboembolism after pancreaticoduodenectomy[J].BMC Surg, 2023, 23(1):25.
|
| [17] |
全国肺栓塞和深静脉血栓形成防治能力建设项目办公室. 中国静脉血栓栓塞症疾病负担报告(2023)[M].北京:中国医药科技出版社,2023.
|
| [18] |
National Project Office for Capacity Building in Prevention and Treatment of Pulmonary Embolism and Deep Vein Thrombosis. Report on disease burden of venous thromboembolism in China(2023)[M]. Beijing: China Medical Science and Technology Press,2023.
|
| [19] |
中华人民共和国国家卫生健康委员会. 临床用血技术规范(2025 版)[S].北京:中国标准出版社,2025.
|
| [20] |
National Health Commission of the People′s Republic of China. Technical specifications for clinical blood use (2025 edition)[S]. Beijing: China Standards Press,2025.
|
| [21] |
WANG C, KOU H, LI X, et al. Association between preoperative blood transfusion and postoperative venous thromboembolism: a review and meta-analysis[J].Ann Vasc Surg, 2021, 73:463-472.
|
| [22] |
SEDRA S, MALLICK R, NAYAK A L, et al. Venous thromboembolism after blood transfusions in women undergoing hysterectomy for non-malignant indications: a retrospective cohort study[J].J Obstet Gynaecol Can, 2021, 43(2):167-174.
|
| [23] |
GOEL R, PLIMIER C, LEE C, et al. Blood donor, component, and recipient-specific factors associated with venous thromboembolism in transfused hospitalized adult patients: data from the Recipient Epidemiology and Donor Evaluation Study-III(REDS-III)[J].Transfusion, 2023, 63(5):925-932.
|
| [24] |
武丽芳,陆华,许桂平. 血液辐照对悬浮红细胞中红细胞微粒释放及创伤患者深静脉血栓形成的影响[J].重庆医学,2024, 53(6):844-849.
|
| [25] |
WU L F, LU H, XU G P. Effects of blood irradiation on release of erythrocyte microparticles in suspended red blood cells and deep venous thrombosis in trauma patients[J].Chongqing Med, 2024, 53(6):844-849.
|
| [26] |
CARSON J L, STANWORTH S J, DENNIS J A, et al. Transfusion thresholds and other strategies for guiding red blood cell transfusion[J].Cochrane Database Syst Rev, 2025, 10(10):CD002042.
|
| [27] |
陈诚,夏荣. 红细胞储存损伤研究进展[J].中国输血杂志,2024, 37(12):1445-1449.
|
| [28] |
CHEN C, XIA R. Research progress of red blood cell storage lesion[J].Chin J Blood Transfusion, 2024, 37 (12):1445-1449.
|
| [29] |
KIM Y, GOODMAN D M, JUNG D A, et al. Microparticles from aged packed red blood cell units stimulate pulmonary microthrombus formation via P-selectin[J].Thromb Res, 2020, 185:160-166.
|
| [30] |
LO B D, QAYUM O, PENBERTHY K K, et al. Dose-dependent effects of red blood cell transfusion and case mix index on venous thromboembolic events in spine surgery[J].Vox Sang, 2023, 118(1):76-83.
|